Braeckman, J., & Michielsen, D. (2014). Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard(®)/Depo-Eligard(®)) for advanced prostate cancer in daily practice: A Belgian prospective non-interventional study. Termedia Publishing House.
Stile di citazione ChicagoBraeckman, Johan, e Dirk Michielsen. Efficacy and Tolerability of 1- and 3-month Leuprorelin Acetate Depot Formulations (Eligard(®)/Depo-Eligard(®)) for Advanced Prostate Cancer in Daily Practice: A Belgian Prospective Non-interventional Study. Termedia Publishing House, 2014.
Citazione MLABraeckman, Johan, e Dirk Michielsen. Efficacy and Tolerability of 1- and 3-month Leuprorelin Acetate Depot Formulations (Eligard(®)/Depo-Eligard(®)) for Advanced Prostate Cancer in Daily Practice: A Belgian Prospective Non-interventional Study. Termedia Publishing House, 2014.